{"PubmedArticle": [{"MedlineCitation": {"InvestigatorList": [], "SpaceFlightMission": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "OtherID": [], "PMID": "18701641", "DateCompleted": {"Year": "2008", "Month": "12", "Day": "16"}, "DateRevised": {"Year": "2013", "Month": "11", "Day": "21"}, "Article": {"Language": ["eng"], "ELocationID": ["10.1177/0269881108091259"], "ArticleDate": [], "Journal": {"ISSN": "0269-8811", "JournalIssue": {"Volume": "22", "Issue": "5", "PubDate": {"Year": "2008", "Month": "Jul"}}, "Title": "Journal of psychopharmacology (Oxford, England)", "ISOAbbreviation": "J Psychopharmacol"}, "ArticleTitle": "Homeopathic pathogenetic trials produce more specific than non-specific symptoms: results from two double-blind placebo controlled trials.", "Pagination": {"StartPage": "543", "EndPage": "552", "MedlinePgn": "543-52"}, "Abstract": {"AbstractText": ["We conducted two parallel, blinded homeopathic pathogenetic trials conducted at two different sites to determine whether symptoms reported by healthy volunteers were significantly different for homeopathic remedies than for placebos. Study 1 used a two-armed design, testing ozone against placebo. Study 2 used a three-armed design, testing ozone and iridium against placebo. We found significantly more remedy-specific symptoms in provers taking ozone or iridium than in provers taking placebo in the three-armed trial and in both trials pooled for ozone and placebo. We, therefore, conclude that homeopathic remedies produce more symptoms typical for a remedy than non-typical symptoms. The results furthermore suggest a somewhat non-classical pattern because symptoms of one remedy appear to be mimicked in the other trial arm. This might be indicative of entanglement in homeopathic systems."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Social Sciences and European Office of the Samueli Institute for Information Biology, University of Northampton, Northampton, UK. harald.walach@northampton.ac.uk"}], "Identifier": [], "LastName": "Walach", "ForeName": "H", "Initials": "H"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "M\u00f6llinger", "ForeName": "H", "Initials": "H"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Sherr", "ForeName": "J", "Initials": "J"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Schneider", "ForeName": "R", "Initials": "R"}], "PublicationTypeList": ["Journal Article", "Multicenter Study", "Randomized Controlled Trial", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "J Psychopharmacol", "NlmUniqueID": "8907828", "ISSNLinking": "0269-8811"}, "ChemicalList": [{"RegistryNumber": "44448S9773", "NameOfSubstance": "Iridium"}, {"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Adult"}, {"QualifierName": [], "DescriptorName": "Double-Blind Method"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": ["methods"], "DescriptorName": "Homeopathy"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Iridium"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Middle Aged"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Ozone"}, {"QualifierName": [], "DescriptorName": "Pilot Projects"}, {"QualifierName": [], "DescriptorName": "Placebo Effect"}, {"QualifierName": [], "DescriptorName": "Research Design"}, {"QualifierName": [], "DescriptorName": "Young Adult"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2008", "Month": "8", "Day": "15", "Hour": "9", "Minute": "0"}, {"Year": "2008", "Month": "12", "Day": "17", "Hour": "9", "Minute": "0"}, {"Year": "2008", "Month": "8", "Day": "15", "Hour": "9", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["18701641", "10.1177/0269881108091259", "22/5/543"]}}], "PubmedBookArticle": []}